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INTRODUCTION

Sulfur mustard (SM) is a potent vesicant employed as a chemical weapon in various
conflicts during the 2 0 th century (1, 2) . It functions as a powerful alkylator and highly cytotoxic blisterogen in both humans and animals (1) (2) (3) (4) (5) (6) (7) (8) (9) . Skin exposed to SM develops erythema within 30 minutes to several hours after exposure followed by edema, vesicle and blister formation, ulceration, necrosis and desquamation (2, 7, 8, 10) . The severity of lesions observed after exposure to SM has emphasized the need for an efficient pharmacological antidote against its vesicating activity. The powerful alkylating activity of SM (11) (12) (13) results from its conversion, in aqueous solution, to the highly electrophilic ethylene episulfonium derivative (2) which can be neutralized by nucleophilic agents. Protection against SM might be achieved by glutathione derivatives (14, 15) , cysteine esters (16) and a cysteine precursor (17) . Despite having some beneficial effects, these agents were not efficacious enough to be used as antidotes. Additional agents, such as arginine analogs (18) (19) (20) (21) (22) , a calcium channel blocker (23) , niacinamide (24) and its combination with promethazine and indomethacin (25) exhibited weak therapeutic effects as post-exposure treatment against SM in experimental animals, although some of these agents were beneficial in in vitro and in vivo systems, particularly if treated prophylactically. Therefore, we undertook the development of efficacious topical antidote for treatment of mustard gas-exposed victims.
BODY
IODINE PROTECTS AGAINST SM
In an attempt to adopt a different approach for addressing this issue, we assumed that the divalent sulfur atom of SM [S(CH 2 CH 2 C1) 2 treatment by improving the iodine formulation. Our experience showed that iodine is more efficacious than povidone-iodine, a polyvinylpyrrolidone-iodine complex (27-29, 34). The currently available iodine preparations contain sodium or potassium iodide, believed to form the water-soluble 13" ion. However, the efficacy of the new iodine formulation was significantly improved due to employment of tetraglycol as solvent without iodide addition; (a patent (34) was filed) which enables 50% water content without iodine precipitation. It is assumed that under these circumstances iodine retains its molecular form i.e. 12 , a more hydrophobic molecule than 13", resulting in enhanced skin penetration and improved biological activity. and parenteral treatments with NSAIDs, including indomethacin and olvanyl, against skin toxicity of SM. We have also shown that incorporation of anti-inflammatory agents into the iodine formulation improved the counter-irritating activity of the preparation in the haired guinea pig model. During the second year of project we tested the effect of the combination of iodine and anti-inflammatory agents on hairless guinea pigs at both single and multiple treatments.
Despite the information about COX involvement in SM-indcued dermal toxicity, no information is available on the role of other inflammatory mediators such as interleukins and tumor necrosis factor-alpha TNFa in very early stages of exposure, and how iodine affects the levels of these inflammatory mediators. In order to address this issue we adopted the following approaches: 
EXPERIMENTAL PROCEDURES
Hairless guinea pigs
The animals were anesthetized by 30 mg/kg pentobarbital sodium ip. Backs were cleaned with wet soft white paper and let to dry out before the beginning of experiment. Six sites (three on each side) of each back were exposed to SM vapor for 16 min. Iodine formulation was applied on 3 exposure site of each animal while the other 3 SM-exposed sites of the animal were treated with iodine vehicle. Iodine was applied 10 min after SM exposure. Animals were evaluated 2 days after exposure.
Haired guinea pigs
Backs of haired guinea pigs were shaved 24 hours prior the experiment. The animals were anesthetized by 30 mg/kg pentobarbital sodium ip. Backs were cleaned with wet soft white paper and let to dry out before the beginning of experiment. Six sites (three on each side) of each back were exposed to 1 tl SM. Iodine formulation was applied 20 min after SM exposure. Five hours after exposure the animals were sacrificed by 100 mg/kg pentobarbital sodium ip. Skin samples were removed and fixed in 10% neutral-buffered formalin, embedded in paraffin, sectioned at 5-6 mm, and stained with hematoxylin and ethanol until processing, embedded in paraffin, and sectioned at 5-6 gnm; part of them were stained with hematoxylin and eosin (H&E) for histopathological evaluation, and the rest were immunostained for TNF-alpha, COX-1, COX-2, and IL-lbeta.
In an additional series of experiments, antiTNF-alpha antibodies were diluted appropriately with 0.9% NaCl and iv-injected (1 and 2 gg in 0.25ml/30g BW) into mice 30 min after SM exposure. The inner side of the ear was exposed to 0.08 mg SM (5gl of 1:80 dilution in dichloromethane) so that the active material was uniformly spread on the outer ear surface. Mouse-ear thickness was measured 48 h after exposure using a micrometer (Model PK-0505, Mitutoyo Corporation, Japan). Edema was assessed by the difference between ear thicknesses measured prior to and after exposure. Animals were sacrificed 48 h following exposure using 100 mg/kg sodium pentobarbital ip. Ear specimens were removed, fixed in 10% neutral-buffered formalin for 24 h then in 70% ethyl alcohol until processing, embedded in paraffin, sectioned at 5-6 [im, and stained with H&E for histopathological evaluation.
Immunostaining procedure.
For immunohistochemistry, tissues were fixed in periodate-lysine-paraformaldehyde, processed routinely and paraffin-embedded. Serial sections (6 rtm) of mouse skin were stained for TNF-alpha, IL-I-beta, COX-1 and COX-2. Detailed Sections were deparaffinized, hydrated and blocked for endogenous peroxidase staining. Heat-induced epitope retrieval was performed for all antibodies using a vegetable steamer.
Histopathological evaluation.
Each mouse-ear section was evaluated in a blinded manner, without the investigator's knowing the identity of the treatment group, and scored for histopathological changes. In the mouse ear the entire section, including inner and 
Evaluation of cell proliferation
Formalin-fixed, paraffin-embedded skin sections were deparaffinized and hydrated using xylene and ethanol. Antigen retrieval was performed using 2N HCL and trypsin digestion. BRDU was detected using a Vector@ (Burlingame, CA) mouse peroxidase kit according to the manufacturer's recommendation. The primary antibody (Dako® Corporation, Carpinteria, CA) concentration was 1:400. Visualization of the antibody complex was achieved using DAB Chromagen system (Dako•.
To score the BRDU stain, a blind count was conducted at 200X magnification under a light microscope (Olympus® BX50). For each skin section, the number of total positive stained cells for BRDU was counted per unit length (mm). An average was calculated for each treatment group.
RESULTS
Effect of iodine formulation on SM-induced skin lesions
Effect of topical iodine against SM-induced skin lesions in the haired guinea pig 5 hours after exposure histopathological findings indicated the epidermis from the control animals (either not treated or treated with the vehicle) and those of the iodine treated animals appeared to be of normal thickness, without any alterations in this layer or in the dermis. The skin samples from the animals treated either with the sulfur mustard (SM) and SM + Vehicle were characterized by epidermal thickening due to swelling and clearing of chromatin of the nuclei. Dermal polymorphonuclear (PMNL) cell infiltration was noted.
Histopathology indicates an acute inflammatory response to SM treated skin ( Fig. 1 ).
Effect of topical iodine on cell proliferation (by BUDR) in guinea pig skin exposed to
SM
The BRDU cell proliferation data ( Proliferation does not return to untreated or vehicle treatment groups' level in the SM + Iodine treated skin.
Effect of SM followed by iodine treatment on levels of TNF-alpha and other inflammatory mediators in the mouse ear skin at short time intervals after exposure
SM-induced inflammation 3 and 8 h after exposure
Histological evaluation of mouse ear 3 h after SM exposure revealed neutrophilia consisting of acute inflammatory-cell aggregates in the vascular bed close to the irritant-exposed area (Fig. 3A) and their adherence to the endothelium and/or crossing through the blood vessel wall (Fig. 3B ). This appearance reflects the earliest stage of histomorphological changes following exposure to the irritant.
Evaluation of the ear 8 h after SM exposure demonstrated the adherence of the neutrophils to the endothelium, and/or crossing through the vessel wall, and infiltrating the adjacent dermis (Fig. 3C, D) .
SM-induced TNF-alpha immunostaining and effect of topical iodine
positive neutrophils within the lumen of the blood vessel adhered to the endothelium and was present within the dermis (Fig. 3F ) ,while the control animal showed few neutrophils within the blood vessel, most of them TNF-alpha-negative (Fig. 3G ). When skin was treated with iodine after SM exposure, however, no inflammatory cells in the blood vessel were seen in tissue sampled 3 h following exposure; 8 h after exposure, blood vessels contained only very few inflammatory cells that were TNF-alpha-positive ( Fig.   3H, I ). This occurrence contrasts with our findings in the case of SM exposure (Fig. 3F) or SM exposure followed by treatment with the iodine vehicle (Fig. 3J) , in which blood vessels contained numerous in.flammatory cells that were TNF-alpha-positive.
Sulfur mustard did not cause significant changes in other inflammatory mediators such as IL-lbeta, COX-1, and COX-2 at time intervals of 3 and 8 h after SM exposure
Effect of anti TNF-alpha antibodies on SM-induced skin lesions in the mouse ear model.
The involvement of TNF-alpha in the inflammatory process elicited by the irritant led us to test the effect of antiTNF-alpha antibodies against SM-induced skin lesions.
Administration of 1 ig and 2ýtg per 30g body weight of antiTNF-alpha antibodies significantly reduced ear edema by 49% and 30%, respectively (Fig. 4) . These findings were corroborated by quantitative analysis of the histological findings (Table 1) showing a statistically significant reduction of 46% in acute inflammation and no signs of "14 subacute inflammation in the treated group, in contrast to the control group (SM only) (Table 1) . Although not statistically significant, the other epidermal (microblister formation, ulceration, and epidermal necrosis, Table 1 ) and dermal (neutrophilia, hemorrhage, and dermal necrosis, Table 1 ) parameters also became markedly reduced in the antibodies-treated group, in comparison to the control group.
Effect of single and multiple topical treatments of hairless guinea pigs with iodine Each of the HaCaT cell lines was grown in Dulbecco's modified Eagle's medium/F-12 containing 10% fetal calf serum, 4mM Glutamine, 100 units/tl penicillin, 100 ptg/ml streptomycin and 250 ng/ml amphotericin B at 37 0 C in a humidified incubator supplemented with 94% air/ 6% CO 2 . Cells were grown in a 25 diameter flask in a volume of 3 ml. Splitting was performed every 3-4 days by removal of the medium and the addition of trypsin. Once the cells were trypsinated, conditioning with the same volume of medium was performed followed by centrifugation at 4000 rpm for 7 minutes.
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The trypsin-medium was removed, the cells were resuspended and transferred to a fresh medium so the final concentration of cells was diluted to 1/10 of the initial value. After splitting cells were grown in serum-free medium for 24 hours.
Experimental approach
Exposure of HaCaT cells to lysophosphatidic acid (LPA) results in production of hydrogen peroxide that can be monitored by conversion to hydroxyl radicals by horseradish peroxidase. The formed radical can be monitored by luminescence in the presence of luminol.
Luminescence assay
The reaction mixture contained 0.2ml cells (10 6 /ml) suspended in Hank's balanced salt solution (HBSS), luminol (100gM) and horseradish peroxidase (1.0 unit/ml), fatty acid free bovine serum albumin (0.2%). Reaction was started by lysophosphatidic acid (LPA)
at the indicated concentrations. The reaction was performed in a white 96-well plate, using Tecan spectrofluoro Plus for luminescence measurement. Each point represents 3 different measurements taken at the peak response of lumuinescence.
Cytotoxicity assay
The cells were pre-incubated with the tested peptide for 4 hours then exposed to SM (1 gM) or hydrogen peroxide (1mM) for 24 hours. Cell Viability was determined by the color (absorbance at 405 nm determined by ELISA reader) is proportional to the number of viable cells.
Results
LPA-induced hydrogen peroxide production in transfected cells AntiTNF-alpha antibody solution was iv-injected (1 gg in 0.25ml/30g BW) into mice 30 min after SM exposure. Animals were sacrificed 48 h after exposure; ears were fixed, embedded in paraffin, sectioned, and stained with H&E for histopathological evaluation as described in Methods. The reactive and inflammatory changes in the epidermis and dermis were assigned a severity grade of 0-4 representing unremarkable, minimal, mild, moderate, and marked changes, respectively. Results are expressed as mean ±SE using the Mann Whitney test for statistical evaluation of the differences between the control and antibody-injected groups. SM (n=6); SM + Ab (n=8).
• p < 0.03. 
